Abstract
This investigation was conducted to evaluate the tissue kallikrein activity in the synovial and paw tissues of control, non-treated adjuvant arthritic and adjuvant arthritic rats treated either with indomethacin or prednisolone. Adjuvant arthritis was induced in male Sprague–Dawley rats in the right knee by injecting 0.05 ml of a fine suspension of heat-killed Mycobacterium tubercle bacilli in liquid paraffin (5 mg/ml). Indomethacin (2.5 mg/kg given orally) and prednisolone (3.0 mg/kg given orally) treatment for 9 days caused a significant reduction (P < 0.001) in knee swelling. In non-treated adjuvant rats, synovial tissue kallikrein levels were raised (P < 0.01) than the synovial tissue kallikrein obtained from control normal rats. Prednisolone treatment resulted in reduction (P < 0.05) and indomethacin treatment produced raise (P < 0.01) in synovial tissue kallikrein levels. In non-treated arthritic rats, the paw tissue kallikrein levels were lower (P < 0.001) than the control rats; whereas, rats treated with prednisolone and indomethacine showed higher levels (P < 0.05) of paw tissue kallikrein. These results may suggest that the prednisone and indomethacin differ in their actions in inflamed synovial tissue kallikrein and have a similar effect in non-inflamed paw tissues.
Similar content being viewed by others
References
Al-Haboubi HA, Bennett D, Sharma JN et al (1986) A synovial amidase acting on tissue kallikrein-selective substrate in clinical and experimental arthritis. Adv Exp Med Biol B 198:404–411
Amundsen E, Putter J, Friberger P et al (1979) Method for determination of glandular kallikrein by means of chromogenic tripeptide substrate. Adv Exp Med Biol A 120:83–95
Edery H, Lewis GP (1963) Kinin-forming activity and histamine in lymph after tissue injury. J Physiol 169:568–573
Farmer SG, Burch RM, meeker SA et al (1989) Evidence for a pulmonary B3 bradykinin receptor. Mol Pharmacol 36:1–8
Newbould BB (1963) Chemotherapy of arthritis induced in rats by injection of Mycobacterial adjuvant. Br J Pharmacol 21:127–136
Regoli D, Barabe J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1–46
Sharma JN (1991) The role of kinin system in joint inflammatory disease. Eur J Rheumatol Inflamm 11:30–37
Sharma JN (1993) Therapeutic prospects of bradykinin receptor antagonists. Gen Pharmacol 24:267–274
Sharma JN (2005) The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection. Inflammopharmacology 12:591–596
Sharma JN, Buchanan WW (1994) Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Exp Toxicol Pathol 46:421–433
Sharma JN, Sharma JN (1977) Comparison of anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by Mycobacterial adjuvant. Arzneim-Forsh 27:1455–1457
Sharma JN, Wirth KJ (1996) Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikrein. Gen Pharmacol 27:133–136
Sharma JN, Zeitlin IJ, Deodhar SD et al (1983) Detection of kallikrein-like activity in the inflamed synovial tissue. Arch Int Pharmacodyn Ther 262:279–286
Sharma JN, Zubaid M, Khan BZSJ et al (2000) Pathophysiological activities of the kallikrein-kinin system with emphasis on the cardiovascular disorders. Inflammopharmacology 8:219–241
Star MS, West GB (1967) Bradykinin and oedema formation in heated paw of rats. Br J Pharmacol 31:178–184
Van Arman CG, Nuss GW (1969) Plasma bradykininogen levels in adjuvant arthritis and carrageenan inflammation. J Pathol 99:245–250
Waller DG, Bhatia SS, Campbell SK et al (1990) active and inactive urinary kallikrein in man: effect of dieresis and antidiuresis. Clin Sci 79:117–121
Yamaguchi Y, Tanaka Y, Yamada K et al (1989) Abnormal lipid metabolism in adjuvant arthritic rats. Jpn J Pharmacol 50:377–386
Zach HP, Werle E (1972) Changes in kininogen content of serum and some organs during injury and inflammation in rats. Adv Exp Med Biol 21:371–379
Zach HP, Werle E (1973) Uber den kininnogen-gehalt von serum und plasma nach gewebsschadigung bei ratten. Arch Pharmacol 276:167–173
Acknowledgments
This work was carried out in the Department of Pharmacology, School of Medical Sciences, USM, Kubang Kerian, Malaysia and was supported by a Research and Development Grant from the Ministry of Science and Technology of Malaysia to JNS. Miss Khor Lee Kean provided an excellent technical support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, J.N. Modifications in tissue kallikrein activity with indomethacin and prednisolone treatment in arthritic rats. Inflammopharmacol 18, 113–117 (2010). https://doi.org/10.1007/s10787-010-0034-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-010-0034-8